Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CASR | P41180 | 3/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.30 |
| ▸ | ERN1 | O75460 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18221375 | 0.84 | FFAR4 (0.35) | CYP17A1FFAR4ALOX5GABRA1GABRB2 | |
| SCHEMBL13025705 | 0.80 | FFAR4 (0.32) | CYP17A1FFAR4ALOX5GABRA1GABRB2 | |
| SCHEMBL13394234 | 0.76 | ALOX5 (0.34) | ALOX5GABRA1GABRB2CNR2GPR52 | |
| SCHEMBL16692266 | 0.75 | CHKA (0.34) | FFAR4GPR52 | |
| SCHEMBL17590235 | 0.73 | FFAR4 (0.38) | FFAR4GABRA1GABRB2 | |
| SCHEMBL15722957 | 0.72 | FFAR4 (0.31) | FFAR4 | |
| SCHEMBL18134250 | 0.71 | ALOX5 (0.36) | CYP17A1ALOX5GABRA1GABRB2CNR2 | |
| SCHEMBL13235488 | 0.71 | FFAR4 (0.35) | FFAR4GABRA1GABRB2 | |
| SCHEMBL17522270 | 0.70 | FFAR4 (0.36) | FFAR4ALOX5GABRA1GABRB2 | |
| SCHEMBL16803048 | 0.70 | TAAR1 (0.35) | GPR52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1731493-B1 | BENZENE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | CHISSO CORP (JP) | 2011-03-23 | — | — | EP | disclosed |